CD274 and squamous cell carcinoma: In the non-adenocarcinoma group (n = 188), a strong PD-L1 expression was seen in 26.6% of in patients with squamous cell carcinoma (n = 139) and in 26.5% of the non-squamous cell carcinoma population (n = 49), respectively.